Lubrano V, Balzan S, Papa A
Mol Cell Biochem. 2023; 479(9):2245-2254.
PMID: 37789136
DOI: 10.1007/s11010-023-04859-0.
Reyes C, Nova-Lamperti E, Duran-Sandoval D, Rojas D, Gajardo J, Guzman-Gutierrez E
Int J Mol Sci. 2022; 23(13).
PMID: 35806336
PMC: 9266330.
DOI: 10.3390/ijms23137329.
Catar R, Chen L, Zhao H, Wu D, Kamhieh-Milz J, Lucht C
Cells. 2022; 11(2).
PMID: 35053320
PMC: 8774144.
DOI: 10.3390/cells11020204.
Taskin H, Kocael A, Kocael P, Zengin K, Al M, Sozer V
Surg Endosc. 2022; 36(4):2643-2652.
PMID: 35044516
DOI: 10.1007/s00464-021-08989-8.
Hasimbegovic E, Schweiger V, Kastner N, Spannbauer A, Traxler D, Lukovic D
Genes (Basel). 2021; 12(9).
PMID: 34573439
PMC: 8469243.
DOI: 10.3390/genes12091457.
Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1.
Mentrup T, Cabrera-Cabrera F, Schroder B
Front Cardiovasc Med. 2021; 7:594441.
PMID: 33553253
PMC: 7856673.
DOI: 10.3389/fcvm.2020.594441.
Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development.
Robichaux 3rd W, Mei F, Yang W, Wang H, Sun H, Zhou Z
Arterioscler Thromb Vasc Biol. 2020; 40(12):e322-e335.
PMID: 33054390
PMC: 7831851.
DOI: 10.1161/ATVBAHA.119.314238.
Hsa-miRNA-23a-3p promotes atherogenesis in a novel mouse model of atherosclerosis.
Guo J, Mei H, Sheng Z, Meng Q, Veniant M, Yin H
J Lipid Res. 2020; 61(12):1764-1775.
PMID: 33008925
PMC: 7707179.
DOI: 10.1194/jlr.RA120001121.
Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.
Mentrup T, Theodorou K, Cabrera-Cabrera F, Helbig A, Happ K, Gijbels M
J Exp Med. 2019; 216(4):807-830.
PMID: 30819724
PMC: 6446863.
DOI: 10.1084/jem.20171438.
Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
Liu J, Liu Y, Jia K, Huo Z, Huo Q, Liu Z
Medicine (Baltimore). 2018; 97(17):e0366.
PMID: 29702981
PMC: 5944531.
DOI: 10.1097/MD.0000000000010366.
MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo.
Liu M, Tao G, Liu Q, Liu K, Yang X
Int J Mol Med. 2017; 40(1):57-64.
PMID: 28535009
PMC: 5466378.
DOI: 10.3892/ijmm.2017.2995.
Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
Wang P, He L, Shen G, Li R, Yang J
Inflammopharmacology. 2017; 25(6):633-642.
PMID: 28365854
DOI: 10.1007/s10787-017-0341-4.
Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway.
Zhou Y, Cao X, Liu Z, Cao Y, Liu C, Zhang Y
PLoS One. 2016; 11(1):e0146777.
PMID: 26752047
PMC: 4709184.
DOI: 10.1371/journal.pone.0146777.
The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding.
Morini E, Rizzacasa B, Pucci S, Polidoro C, Ferre F, Caporossi D
J Cell Mol Med. 2015; 20(1):181-7.
PMID: 26542080
PMC: 4717858.
DOI: 10.1111/jcmm.12716.
Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
Liu Z, Xu S, Huang X, Wang J, Gao S, Li H
Br J Pharmacol. 2015; 172(23):5661-75.
PMID: 25572313
PMC: 4667869.
DOI: 10.1111/bph.13068.
LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.
Shiraki T, Aoyama T, Yokoyama C, Hayakawa Y, Tanaka T, Nishigaki K
PLoS One. 2014; 9(12):e114542.
PMID: 25514797
PMC: 4267738.
DOI: 10.1371/journal.pone.0114542.
α5β1 integrin signaling mediates oxidized low-density lipoprotein-induced inflammation and early atherosclerosis.
Yurdagul Jr A, Green J, Albert P, McInnis M, Mazar A, Orr A
Arterioscler Thromb Vasc Biol. 2014; 34(7):1362-73.
PMID: 24833794
PMC: 4096780.
DOI: 10.1161/ATVBAHA.114.303863.
Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.
Vos J, Mathijs I, Xavier C, Massa S, Wernery U, Bouwens L
Mol Imaging Biol. 2014; 16(5):690-8.
PMID: 24687730
DOI: 10.1007/s11307-014-0731-6.
Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress.
Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y
PLoS One. 2013; 8(6):e65477.
PMID: 23799016
PMC: 3684610.
DOI: 10.1371/journal.pone.0065477.
Vinpocetine attenuates lipid accumulation and atherosclerosis formation.
Cai Y, Li J, Yan C
Biochem Biophys Res Commun. 2013; 434(3):439-43.
PMID: 23583194
PMC: 3682500.
DOI: 10.1016/j.bbrc.2013.03.092.